Literature DB >> 15095050

The role of functional neuroimaging in the differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy.

Thomas Eckert1, David Eidelberg.   

Abstract

Parkinsonism is a symptom of a number of neurodegenerative disorders in the elderly. Even though clinical criteria for various parkinsonian disorders have been developed recently, the differential diagnosis of parkinsonian disorders based on clinical symptoms remains unsatisfactory, particularly in early disease stages. Early differential diagnosis on the other hand is important as prognosis and treatment options differ substantially. Multiple system atrophy (MSA) is one of the major differential diagnoses of idiopathic Parkinson's disease (PD). Radiotracer-based imaging methods such as positron emission tomography (PET) remain the established method for differential diagnosis of parkinsonian disorders. The following paper provides a review of different PET imaging methods for the differential diagnosis of PD and MSA patients.

Entities:  

Mesh:

Year:  2004        PMID: 15095050     DOI: 10.1007/s10286-004-0167-1

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  8 in total

Review 1.  How to diagnose MSA early: the role of magnetic resonance imaging.

Authors:  K Seppi; M F H Schocke; G K Wenning; W Poewe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

2.  Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeys.

Authors:  Liming Luan; Feng Ding; Yi Ai; Anders Andersen; Peter Hardy; Eric Forman; Greg A Gerhardt; Don M Gash; Richard Grondin; Zhiming Zhang
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

Review 3.  Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease.

Authors:  Shigeki Hirano; Thomas Eckert; Toni Flanagan; David Eidelberg
Journal:  Mov Disord       Date:  2009       Impact factor: 10.338

4.  Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [123I]beta-CIT SPECT analysis.

Authors:  Christoph Scherfler; Sylvia M Boesch; Eveline Donnemiller; Klaus Seppi; Helga Weirich-Schwaiger; Georg Goebel; Irene Virgolini; Gregor K Wenning; Werner Poewe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-13       Impact factor: 9.236

Review 5.  Neuroimaging and therapeutics in movement disorders.

Authors:  Thomas Eckert; David Eidelberg
Journal:  NeuroRx       Date:  2005-04

6.  Quantification of Parkinson's disease-related network expression with ECD SPECT.

Authors:  Thomas Eckert; Koen Van Laere; Chengke Tang; Daniel E Lewis; Christine Edwards; Patrick Santens; David Eidelberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-10       Impact factor: 9.236

7.  Functional brain imaging: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-12-01

8.  Clinical features, MRI, and 18F-FDG-PET in differential diagnosis of Parkinson disease from multiple system atrophy.

Authors:  Ping Zhao; Benshu Zhang; Shuo Gao; Xin Li
Journal:  Brain Behav       Date:  2020-09-17       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.